| Drug General Information |
| Drug ID |
D0E7MB
|
| Drug Name |
Dalteparin Sodium
|
| Synonyms |
Fragmin; Fragmin
|
| Drug Type |
Small molecular drug
|
| Indication |
Hematology [ICD10:D50-D77]
|
Approved |
[1]
|
|---|
| Company |
Pfizer Inc
|
| Formula |
C12H17NO20S3-4
|
| PubChem Compound ID |
|
| Target and Pathway |
| Target(s) |
Coagulation factor Xa |
Target Info |
Modulator |
[2]
|
|---|
|
KEGG Pathway
|
Complement and coagulation cascades
|
|
PANTHER Pathway
|
Blood coagulation
|
|
Pathway Interaction Database
|
Beta2 integrin cell surface interactions
|
|
PathWhiz Pathway
|
Coagulation
|
|
Reactome
|
Extrinsic Pathway of Fibrin Clot Formation
|
|
Intrinsic Pathway of Fibrin Clot Formation
|
|
Common Pathway of Fibrin Clot Formation
|
|
Gamma-carboxylation of protein precursors
|
|
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
|
|
Removal of aminoterminal propeptides from gamma-carboxylated proteins
|
|
WikiPathways
|
Complement and Coagulation Cascades
|
|
Human Complement System
|
|
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
|
|
Blood Clotting Cascade
|
|
Formation of Fibrin Clot (Clotting Cascade)
|
| References |
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
|---|
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. |
|---|
